Ravi Kumar faces two-year ban for failing dope test

Image
ANI Others
Last Updated : Dec 11 2019 | 3:05 PM IST

Indian shooter Ravi Kumar, who early this year failed the dope test, has been banned for two years by the National Anti-Doping Agency (NADA) on Wednesday.

Kumar was tested positive for using Propranolol on July 19 and the hearing completed on November 28. After the completion of the hearing, the order was reserved.

After a hearing, the disciplinary committee said that Kumar has been banned for two years.

Earlier in the day, Indian boxer Sumit Sangwan failed the dope test after being tested positive for a banned substance.

In a formal notice to Sangwan (91kg), NADA said Acetazolamide was found in the athlete's samples.

"On October 10, 2019, a NADA Doping Control Officer (DCO) collected a Urine Sample from you. Assisted by the DCO, you split the Sample into two separate bottles, which were given reference numbers A 6366879 (the A Sample) and B 6366879 (the B Sample)," NADA said in the notice.

"Both samples were transported to the World Anti-Doping Agency (WADA)- accredited Laboratory, the Antidoping Lab Qatar-Doha. The Laboratory analysed the A Sample in accordance with the procedure set out in WADA's International Standard for Laboratories. Analysis of the 'A' Sample returned an Adverse Analytical Finding for Acetazolamide, Diuretics and masking agents."

Acetazolamide is listed as Diuretics and masking agents under S5 of WADA's 2019 Prohibited List.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 11 2019 | 2:51 PM IST

Next Story